Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

CASI Pharmaceuticals Inc (NASDAQ:CASI)

1.34
Delayed Data
As of Sep 04
 +0.01 / +0.75%
Today’s Change
1.07
Today|||52-Week Range
2.13
+0.75%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Quarter 2
2015
Revenue and IncomeNet Revenues0.0023.7K23.7K24.0K
 
 
 
 
Cost of Goods Sold0.007.5K747.672.7K
 
 
 
 
Depreciation And Amortization13.5K15.5K16.5K16.7K
 
 
 
 
 
 
Operating ExpensesGross Income-13.5K794.006.4K4.6K
 
 
 
 
 
General Expenses1.8M1.6M1.8M2.1M
 
 
 
 
 
Research And Development697.0K784.0K865.0K1.2M
 
 
 
 
 
Total Operating Expenses1.8M1.6M1.8M2.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-1.8M-1.6M-1.8M-2.1M
 
 
 
 
 
Extraordinary Credit0.0018.3K0.000.00
 
 
Extraordinary Charge-19.7M0.00-6.8K-11.5K
 
 
 
 
Interest Expense On Debt3.5K24.5K24.2K24.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-21.5M-1.6M-1.8M-2.1M
 
 
 
 
 
Net Income-21.5M-1.6M-1.8M-2.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS27.8M32.4M32.4M32.4M
 
 
 
 
 
Shares To Calculate EPS Diluted27.8M32.4M32.4M32.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.77-$0.05-$0.06-$0.06
 
 
 
 
 
EPS Diluted-$0.77-$0.05-$0.06-$0.06